Corient Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
41,278
-28,940
-41% -$10.7M 0.02% 493
2026
Q1
$20.5M Buy
70,218
+2,957
+4% +$972K 0.03% 398
2025
Q4
$23.6M Buy
67,261
+7,315
+12% +$2.47M 0.03% 374
2025
Q3
$19.4M Sell
59,946
-12,208
-17% -$3.8M 0.03% 394
2025
Q2
$28.1M Sell
72,154
-3,280
-4% -$1.32M 0.04% 331
2025
Q1
$32.8M Buy
75,434
+3,932
+5% +$1.58M 0.05% 298
2024
Q4
$26.4M Sell
71,502
-9,935
-12% -$4.16M 0.04% 339
2024
Q3
$42.3M Sell
81,437
-1,812
-2% -$968K 0.07% 268
2024
Q2
$45.1M Buy
83,249
+3,605
+5% +$1.91M 0.08% 239
2024
Q1
$41.3M Sell
79,644
-280
-0.4% -$139K 0.07% 257
2023
Q4
$37.7M Sell
79,924
-111
-0.1% -$51.3K 0.07% 268
2023
Q3
$34.9M Buy
80,035
+173
+0.2% +$78.5K 0.08% 256
2023
Q2
$35.5M Sell
79,862
-4,520
-5% -$2.09M 0.08% 244
2023
Q1
$38.8M Buy
84,382
+3,458
+4% +$1.65M 0.1% 192
2022
Q4
$41.5M Buy
+80,924
New +$41.1M 0.15% 156

Other funds holding ELV

Corient Private Wealth's ELV Position: Q2 2026 in Review

Corient Private Wealth reduced its Elevance Health (ELV) stake by 41% in Q2 2026, selling an estimated $10.7M and leaving 41,278 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #493.

Corient Private Wealth first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $45.1M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Corient Private Wealth held 41,278 shares of Elevance Health worth $16M as of Q2 2026.
  • Corient Private Wealth sold 28,940 Elevance Health shares in Q2 2026, an estimated $10.7M.
  • Elevance Health made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #493 holding.
  • Corient Private Wealth first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Elevance Health position peaked at $45.1M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.